PMC:7696151 / 55734-55955
Annnotations
{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7696151","sourcedb":"PMC","sourceid":"7696151","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7696151","text":"In a mouse model of obstetric antiphospholipid syndrome, HCQ, administered in a daily dose of 200 μg per mouse limited placental abnormalities, with an increase of fetal survival, by inhibiting complement activation [95].","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"1611","span":{"begin":5,"end":10},"obj":"Species"},{"id":"1612","span":{"begin":105,"end":110},"obj":"Species"},{"id":"1617","span":{"begin":57,"end":60},"obj":"Chemical"},{"id":"1632","span":{"begin":20,"end":55},"obj":"Disease"}],"attributes":[{"id":"A1611","pred":"tao:has_database_id","subj":"1611","obj":"Tax:10090"},{"id":"A1612","pred":"tao:has_database_id","subj":"1612","obj":"Tax:10090"},{"id":"A1617","pred":"tao:has_database_id","subj":"1617","obj":"MESH:D006886"},{"id":"A1632","pred":"tao:has_database_id","subj":"1632","obj":"MESH:D016736"},{"subj":"1611","pred":"source","obj":"LitCovid-PubTator"},{"subj":"1612","pred":"source","obj":"LitCovid-PubTator"},{"subj":"1617","pred":"source","obj":"LitCovid-PubTator"},{"subj":"1632","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]},{"project":"LitCovid-sentences","denotations":[{"id":"T359","span":{"begin":0,"end":221},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"attributes":[{"subj":"T359","pred":"source","obj":"LitCovid-sentences"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ecb393","default":true},{"id":"LitCovid-sentences","color":"#9993ec"}]}]}}